Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 3,606

Document Document Title
WO/2013/131901A1
The present invention relates to a combination comprising compounds of formula (I): wherein R1to R3, A, X and n are as defined herein, and an additional active agent. The present invention also relates pharmaceutical compositions compris...  
WO/2013/134226A1
The present invention relates to compounds of formula (I) wherein R1 to R3, A, X and n are as defined herein. The compounds of formula (I) are useful as inhibitors of leukotriene A4 hydrolase (LTA4H) and treating LTA4H related disorder. ...  
WO/2013/130792A3
Fluorinated prodrug compounds as can be used for selective streptococcal mevalonate pathway inhibition.  
WO/2013/130792A2
Fluorinated prodrug compounds as can be used for selective streptococcal mevalonate pathway inhibition.  
WO/2013/124363A3
The invention relates to a composition for the oxidative colouring of keratin-containing fibres, in particular human hair, which comprises at least one compound of the formula (I) as oxidation dye precursor of the developer-type.  
WO/2013/125356A1
Provided are: a liquid crystal compound which has high stability with respect to heat, light and the like, high clearing point, low lower limit temperature of the liquid crystal phase, low viscosity, adequate optical anisotropy, large di...  
WO/2013/123222A1
The invention provides processes for preparing intermediates useful for preparing compounds of the formula (IV): or a tautomer or salt thereof, where R1-R5, a, b, X and P2, are as defined in the specification.  
WO/2013/121209A1
A compound of formula I, and its pharmaceutically acceptable salt or salts and physiologically hydrolysable derivatives in free form or salt form: (Formula (I)) wherein either Q1, CR6a and optionally R6b together form a cyclic moiety whe...  
WO/2013/118907A1
An amide compound represented by formula (I) has an excellent pest control effect. (In the formula, Y represents a 3-7 membered saturated heterocyclic ring which contains, as ring-forming component(s), one or more atoms or groups that ar...  
WO/2013/108514A1
A production method for a compound indicated by general formula (V), including a step in which a compound indicated by general formula (II) is obtained by reacting a compound indicated by general formula (I) with an acid. (G1 and G2 each...  
WO/2013/088686A1
This adhesive resin composition contains a foaming adhesive polymer having a structure derived from a Meldrum's acid derivative, or a Meldrum's acid derivative represented by general formula (1) and an adhesive resin.  
WO/2013/083718A1
The present invention relates to a process for the preparation of a precursor for the synthesis of hexanoic acid derived statins and to the use of said precursor in the manufacture of a medicament.  
WO/2013/083719A1
The present invention relates to a process for the preparation of a precursor for the synthesis of hexanoic acid derived statins and to the use of said precursor in the manufacture of a medicament.  
WO/2013/079397A1
Disclosed are certain fluorinated derivatives of Meldrum's acid as novel compounds, preparation methods for the same, their use in Li ion batteries, Li air batteries and Li sulphur batteries as well as solvent compositions, electrolyte c...  
WO/2013/077719A1
The present invention relates to a molecule obtained from Krameria cytisoides for the treatment of inflammatory conditions. Specifically, the present invention relates to a cyclic polymer peroxide having anti-inflammatory pharmacological...  
WO/2013/059194A1
The disclosed subject matter provides certain N-substituted hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In partic...  
WO/2013/059215A1
Disclosed herein are substituted biaryl alkyl amide compounds, methods of synthesizing substituted biaryl alkyl amide compounds and methods of treating diseases and/or conditions with substituted biaryl alkyl amide compounds.  
WO/2013/045681A1
The present invention is directed to an improved process for the preparation of sulfamide derivatives.  
WO/2013/049021A1
The present invention is directed to a process for the preparation of sulfamide derivatives.  
WO/2013/039038A1
This method for producing glycolide involves depolymerizing a glycolic acid oligomer in the presence of a phenolic antioxidant.  
WO/2013/035899A1
The present invention relates to a method for preparing 5-hydroxy-1,3-dioxane (α, α'-isomer of glycerol formal) which is very suitable as a raw material for branched glycerol, and more particularly, to a method for preparing 5-hydroxy-...  
WO/2013/010882A3
The compounds of formula (I) in which L represents a radical of formula (a) or (b), and A1, B1 or A2 and B2 are defined as in claim 1, can be used as herbicides for combating pest plants or as plant growth regulators. The compounds can b...  
WO/2013/010488A1
The present invention relates to the field of pharmaceutical chemistry, specifically relates to a statin intermediate having formula (I) and preparation thereof. The advantages of the method used to prepare the chiral sulfone intermediat...  
WO/2013/004296A1
The present invention relates to a method for making a polymer wherein during ring opening polymerisation is incorporated into the polymer chain at least one cyclic (alkyl) carbonate monomer having the formula (1) wherein Y is optional a...  
WO/2012/176792A1
The present invention relates to a method and a pharmaceutical composition for suppressing immunity, in each of wherein a fatty acid derivative represented by general formula (I) is utilized. The present invention also relates to a metho...  
WO/2012/177357A1
The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume r...  
WO/2012/176856A2
To provide a novel pesticide. The present invention provides a compound represented by the formula (I) or its salt, and a pesticide containing it as an active ingredient: (I) wherein each of R1 and R2 is a hydrogen atom, a halogen atom, ...  
WO/2012/177357A9
The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume r...  
WO/2012/175650A1
The present invention relates to a method for the hydrothermolysis of a mono- and/or oligosaccharide-comprising composition which in addition comprises at least one monoalkyl and/or dialkyl ether of a polyalkylene glycol, and also relate...  
WO/2012/169559A1
In order to provide a novel azole derivative, the azole derivative of the present invention is an azole derivative represented by general formula (V'). (In the formula, each of R6 and R7 independently represents a hydrogen atom, an alkyl...  
WO/2012/158107A1
Linear or cyclic carbonates as potential monomers for isocyanate-free polyurethanes and polycarbonates were prepared from polyols and dialkylcarbonatesor diphenyl carbonates. This invention was developed to produce linear or cyclic carbo...  
WO/2012/153950A2
The present invention relates to a method for preparing t-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate having optical activity, which is a core intermediate in the preparation of a variety of HMG-CoA reductase inhibitor...  
WO/2012/153950A3
The present invention relates to a method for preparing t-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate having optical activity, which is a core intermediate in the preparation of a variety of HMG-CoA reductase inhibitor...  
WO/2012/138254A3
The invention relates to medicine and pharmacology. The novel 4,4'-biphenylamide derivatives are pharmacologically active and can be used as new effective allosteric modulators of АМРА receptors for treating Alzheimer's, Parkinson's ...  
WO/2012/136568A1
The invention relates to a method for the removal of the cyclic diester of a 2-hydroxy alkanoic acid from a vapor containing said diester, wherein the vapor is contacted with an aqueous solution so that the diester dissolves in said solu...  
WO/2012/138494A1
A process for making a 2-nitro-1-ethanol derivative of formula III: wherein R3 is as described herein is provided. Novel 2-nitro-1-ethanol derivatives provided.  
WO/2012/130920A1
The invention discloses a method for the preparation of tert-butyl 6-chloro-3,5- dioxohexanoatefrom Meldrum's acid derivative and its use for the preparation of tert-butyl (4R,6S)-(6-hydroxymethyl-2,2-dimethyl-1,3-dioxan-4-yl)acetat e(BH...  
WO/2012/133861A1
An amide compound represented by the formula (I): [wherein, R1, R2, R3, R4, R5, R6, R7, R8, X, W, r, n and Y are as defined in the description] has an excellent control effect on harmful arthropods.  
WO/2012/130919A1
The invention discloses a method for the preparation of tert-butyl 6-chloro-3,5- dioxohexanoate from Meldrum's acid derivative and its use for the preparation of tert-butyl (4R,6S)-(6-hydroxymethyl-2,2-dimethyl-1,3-dioxan-4-yl)acetat e(B...  
WO/2012/129452A8
This invention discloses a series of novel propynoic acid carbamoyl methyl-amides (PACMAs), methods for synthesizing the PACMAs and pharmaceutical compositions containing the PACMAs. These novel compounds and compositions show cytotoxici...  
WO/2012/129452A3
This invention discloses a series of novel propynoic acid carbamoyl methyl-amides (PACMAs), methods for synthesizing the PACMAs and pharmaceutical compositions containing the PACMAs. These novel compounds and compositions show cytotoxici...  
WO/2012/129452A2
This invention discloses a series of novel propynoic acid carbamoyl methyl-amides (PACMAs), methods for synthesizing the PACMAs and pharmaceutical compositions containing the PACMAs. These novel compounds and compositions show cytotoxici...  
WO/2012/125598A1
The present invention relates to compounds of formula (I): wherein R1 to R3, A, X and n are as defined herein. The compounds of formula (I) are useful as inhibitors of leukotriene A4 hydrolase (LTA4H) and treating LTA4H related disorder....  
WO/2012/118196A1
Provided is a method for concentrating an aqueous solution that contains at least 3-hydroxy-2,2-dimethylpropanal and/or a dimer thereof. The concentration method comprises a step wherein at least one substance selected from the group con...  
WO/2012/114347A1
Disclosed herein is a compound of formula (A), its salts, enantiomers, and diastereomers thereof; wherein, Rl and R2 can be (C1-C6) alkyl groups, a phenyl group, a (C5-C7) cycloalkyl groups; X and Y individually selected from H, -N02, -N...  
WO/2012/116250A1
The invention generally relates to functional polymers and hydrogels. More particularly, the invention provides versatile monomers and polymers with well-defined functionalities, e.g., polycarbonates and poly(ester-carbonates), compositi...  
WO/2012/110117A1
Disclosed is a method to prepare a polylactic acid comprising the steps of performing a ring opening polymerization using a catalyst and either a catalyst killer compound or an endcapping additive to obtain a raw polylactic acid of MW gr...  
WO/2012/110118A1
Disclosed is a method to prepare a polylactic acid comprising the steps of: performing a ring opening polymerization using a catalyst and either a catalyst killer compound or an endcapping additive to obtain a raw polylactic acid of MW g...  
WO/2012/107158A1
The invention relates to specific [1,3]-dioxan-5-one compounds, to a process for preparation thereof and to the use thereof as dyes or as fluorescent emitters for organic electroluminescent devices (OLEDs) or for organic light-emitting e...  
WO/2012/104659A1
A compound of Formula (I), and its pharmaceutically acceptable salt or salts and physiologically hydrolysable derivatives in free form or salt form: wherein R1 is independently selected from F, CI, Br, CN, NH2, OH, CHO, COOH, oxo, C1-4al...  

Matches 51 - 100 out of 3,606